Mode
Text Size
Log in / Sign up

General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetesNew management model improves medication use and health for seniors

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider structured management programs to improve medication adherence and lifestyle outcomes in elderly diabetic patients.

This randomized controlled trial was conducted at Qinhuangdao First Hospital to evaluate the impact of a structured general medical management program on older adults with type 2 diabetes and established atherosclerotic cardiovascular disease, such as coronary heart disease or ischemic stroke. The study enrolled a total of 200 participants, with 100 assigned to the intervention group and 100 assigned to the control group. The primary outcome measured was treatment compliance, lifestyle, and clinical indicators over a 12-month follow-up period.

The intervention group received general medical management consisting of personalized health education during hospitalization, community outpatient follow-up after discharge, and specific lifestyle interventions. In contrast, the control group received only routine discharge guidance.

Regarding primary outcomes, the intervention group demonstrated significantly better medication usage for metformin, SGLT2 inhibitors, GLP-1 receptor agonists, aspirin/clopidogrel, statins, and ACE inhibitors/ARBs compared to the control group (P < 0.05). While both groups showed significant reductions in body mass index (BMI) and improvements in glycated hemoglobin and low-density lipoprotein cholesterol (LDL-C), the intervention group specifically showed a significant decrease in smoking rates (P = 0.014). Furthermore, the intervention group demonstrated comprehensive dietary improvements and significantly increased physical activity scores (P < 0.05). A notable difference was observed in creatinine levels, where the intervention group showed significant improvements while the control group experienced significant deterioration (P < 0.001).

Safety data indicated that 95 patients in the intervention group and 91 patients in the control group remained for analysis at the 12-month mark. Specific adverse event rates or tolerability metrics were not reported.

These results suggest that a structured management model may be more effective than standard care for managing complex comorbidities in elderly populations. However, the study is limited by a relatively small sample size of 200 total patients and the absence of specific effect sizes or confidence intervals for most outcomes.

Clinically, these findings suggest that integrating personalized education and community follow-up may improve adherence to multi-drug regimens and lifestyle modifications in older patients with cardiovascular risk. However, because the study does not provide specific effect sizes, the magnitude of benefit remains unclear. Future research is needed to determine if these results are reproducible in larger, more diverse cohorts and to clarify the long-term impact on major adverse cardiovascular events.

How this fits prior evidence

How this fits prior evidence: This finding complements existing knowledge regarding the management of type 2 diabetes and atherosclerotic cardiovascular disease by highlighting the role of structured follow-up. While previous reports noted that Retatrutide shows dose-dependent HbA1c reduction and weight loss in adults with type 2 diabetes, this study focuses on the impact of a general medical management model on medication adherence and lifestyle for those with established cardiovascular complications.

Managing life with both type 2 diabetes and heart disease is a constant balancing act. For many older adults, the challenge is not just taking the right pills, but staying consistent with complex medication schedules while making necessary changes to diet and exercise. When patients struggle to follow these plans, it can lead to worsening health outcomes for their hearts and kidneys.

A study looked at how a structured management model could help these patients stay on track. Researchers recruited 200 older adults who had both type 2 diabetes and established heart disease. Half of the group received a specialized program that included personalized health education during hospital stays, follow-up care in their local communities after being discharged, and specific lifestyle interventions. The other half received only routine discharge instructions.

The results showed a clear difference in how patients managed their health over 12 months. Patients in the special management group were much more likely to keep taking their essential medications, including those for blood sugar and heart health. While both groups saw some improvements in weight and cholesterol levels, only the group with the extra support showed significant improvements in their physical activity and diet. Most importantly, the specialized care helped these patients significantly improve their kidney function markers compared to the group that received standard care.

It is important to keep these findings in perspective. While the results are promising for how we manage chronic diseases, this was a relatively small study involving only 200 people. The researchers did not provide specific measurements for how much the health markers improved or exactly how many people dropped out of the study early. Because it is a single study with a small group size, we cannot say it will work perfectly for every patient.

For patients right now, this means that personalized, ongoing support can be a powerful tool. Instead of just receiving a list of instructions at the end of a hospital visit, having a team provide education and community follow-up may help people stay consistent with their medications and lifestyle changes. It suggests that a more hands-on approach to care could lead to better heart and kidney health for those managing multiple conditions.

What this means for you:
A structured management plan helped older adults with diabetes and heart disease stick to their meds and improve habits.

Study Details

Study typeRct
Sample sizen = 200
EvidenceLevel 2
Follow-up12.0 mo
PublishedJan 2026
View Original Abstract ↓
PURPOSE: To investigate the impact of general practice management on treatment compliance, lifestyle, and clinical indicators in older adults with cardiovascular metabolic comorbidities to provide more effective disease management strategies for this population. PATIENTS AND METHODS: This randomized controlled trial enrolled 200 older adults with type 2 diabetes and established atherosclerotic cardiovascular disease (e.g., coronary heart disease, ischemic stroke) who were discharged from Qinhuangdao First Hospital between November 2021 and May 2023. Patients were randomly divided into intervention and control groups (n = 100 per group). The intervention group received general medical management, including personalized health education during hospitalization, community outpatient follow-up after discharge, and lifestyle interventions. The control group received routine discharge guidance. Changes in medication usage, body mass index (BMI), smoking rate, and clinical indicators, such as glycated hemoglobin, low-density lipoprotein cholesterol, and creatinine levels were evaluated over a 12-month follow-up period. Dietary intake and physical activity were assessed using the Semi-Quantitative Food Frequency Survey Questionnaire and the Physical Activity Scale for the Elderly, respectively. RESULTS: After 12 months, 91 controls and 95 intervention patients remained and were analyzed per-protocol. Within-group analyses revealed that the intervention group successfully maintained high utilization rates of all recommended medications (metformin, SGLT2i, GLP-1RA, aspirin/clopidogrel, statins, ACEI/ARB), whereas the control group experienced significant declines (all P < 0.05). Both groups achieved significant reductions in BMI, but only the intervention group showed a significant decrease in smoking rates (P = 0.014). The intervention group demonstrated comprehensive dietary improvements (e.g., increased nuts, dairy, vegetables, and aquatic products; reduced refined carbohydrates, meats, and salt) and significantly increased physical activity scores (all P < 0.05). Clinically, while both groups achieved reductions in glycated hemoglobin and LDL-C, only the intervention group showed significant improvements in creatinine levels, whereas renal function in the control group significantly deteriorated (P < 0.001). CONCLUSION: A structured general practice management model effectively sustains long-term medication adherence, promotes comprehensive healthy lifestyle modifications, and optimizes key metabolic and renal clinical indicators in older adults with cardiovascular metabolic comorbidities. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2500112212.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.